Predictive diagnostics: closing the precision medicine gap
Drug Discovery World
OCTOBER 6, 2022
TMB is a proxy or predictor for immune activity since, the more foreign a cell becomes, the more likely there is to be an immune response to foreign cells. He is the founder and CEO of Cofactor Genomics, a diagnostic company leveraging the power of RNA and machine learning to build disease models.
52 
Let's personalize your content